stockgist
HomeTop MoversCompaniesConcepts

Market

  • Top Movers
  • Companies
  • Concepts

SEC Filings

  • AI Filing Analysis
  • Financial Reports
  • Current Reports
  • IPO Filings

Ownership

  • Institutional Holdings
  • Insider Trading

About

  • Data updates every 5 min
  • SEC EDGAR Source
© 2025–2026 StockGist|Information only, not investment advice
    1. Companies
    2. NXEN
    stockgist
    HomeTop MoversCompaniesConcepts
    NXEN logo

    Nexien BioPharma, Inc.

    NXEN
    OTC
    Healthcare
    Drug Manufacturers - Specialty & Generic
    Glendale, CO, USnexienbiopharma.com
    —

    At A Glance

    1

    Nexien BioPharma, Inc.

    2

    No significant events in the past 90 days.

    —

    Market Cap

    —

    Revenue

    —

    Net Income

    Fundamentals

    How The Business Makes Money

    Nexien BioPharma, Inc. operates as a pharmaceutical company. It focuses on the formulation, development, and commercialization of cannabinoid-based pharmaceuticals, and pre-clinical and clinical pathways for the treatment of various diseases, medical conditions, and disorders. The company was formerly known as Intiva BioPharma Inc. and changed its name to Nexien BioPharma, Inc. in September 2018. Nexien BioPharma, Inc. is based in Glendale, Colorado.

    Industry Drug Manufacturers - Specialty & Generic
    Activity

    What Changed Recently

    No significant events in the past 90 days.

    Peer Companies

    CompanyPriceChangeMarket CapP/E
    DVLPGolden Developing Solutio...————
    NEPTFNeptune Wellness Solution...————
    IVIXFInvion Limited————
    MCICMultiCorp International, ...————
    IRBSIRBS————
    RGMPRegnum Corp.————
    AQSZFAequus Pharmaceuticals In...————
    XTXXFAdastra Holdings Ltd.————
    Company Profile
    CIK0001625288
    ISINUS65343D1000
    CUSIP65343D100
    Phone303 495 7583
    Address4340 East Kentucky Avenue, Glendale, CO, 80246, US
    SEC EDGAR

    Market

    • Top Movers
    • Companies
    • Concepts

    SEC Filings

    • AI Filing Analysis
    • Financial Reports
    • Current Reports
    • IPO Filings

    Ownership

    • Institutional Holdings
    • Insider Trading

    About

    • Data updates every 5 min
    • SEC EDGAR Source
    © 2025–2026 StockGist|Information only, not investment advice